METASTATIC GASTRO-ESOPHAGEAL ADENOCARCINOMA

Clinical trials for METASTATIC GASTRO-ESOPHAGEAL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC GASTRO-ESOPHAGEAL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC GASTRO-ESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for Tough-to-Treat stomach cancers

Disease control Ongoing

This study is testing if adding a new targeted drug, bemarituzumab, to standard chemotherapy can help control advanced stomach or gastroesophageal cancer that has worsened after initial treatment. It is for adults whose tumors have a specific marker (FGFR2b-positive). The main go…

Matched conditions: METASTATIC GASTRO-ESOPHAGEAL ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

METASTATIC GASTRO-ESOPHAGEAL ADENOCARCINOMA

Get alerted when new METASTATIC GASTRO-ESOPHAGEAL ADENOCARCINOMA trials appear

New hope for Tough-to-Treat stomach cancers